Provided by Tiger Trade Technology Pte. Ltd.

Mizuho

10.94
-0.1300-1.17%
Post-market: 11.300.3600+3.29%19:30 EDT
Volume:2.75M
Turnover:29.94M
Market Cap:133.39B
PE:15.87
High:10.95
Open:10.80
Low:10.73
Close:11.07
52wk High:11.49
52wk Low:6.09
Shares:12.19B
Float Shares:11.07B
Volume Ratio:0.72
T/O Rate:0.02%
Dividend:0.18
Dividend Rate:1.69%
EPS(TTM):0.6892
EPS(LYR):0.6326
ROE:12.49%
ROA:0.48%
PB:1.82
PE(LYR):17.29

Loading ...

Mizuho Securities Adjusts Entergy Price Target to $121 From $122, Maintains Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Adjusts Price Target on Vertiv to $300 From $380, Maintains Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Lifts Price Target on Air Products & Chemicals to $355 From $345, Keeps Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Financial Gr Q1 EPS $0.22 Up From $0.15 YoY, Sales $15.818B Up From $14.736B YoY

Benzinga Earnings
·
Jul 30

Mizuho Financial Group Doubles Share Buyback Program to 200 Billion Yen

MT Newswires Live
·
Jul 30

Mizuho Financial Group's Profit Soars 46% in Fiscal Q1

MT Newswires Live
·
Jul 30

Mizuho Leasing Injects ¥1.08 Billion Into Restricted Stock Benefit Trust

TIPRANKS
·
Jul 30

Mizuho Leasing Delivers Profit Surge in First Quarter, Confirms Full-Year Outlook and Dividend Plan

TIPRANKS
·
Jul 30

Mizuho Doubles Share Buyback to ¥200 Billion and Extends Cancellation Timeline

TIPRANKS
·
Jul 30

Mizuho lifts full-year profit outlook after robust Q1 earnings

TIPRANKS
·
Jul 30

Mizuho Leasing 1Q Net Y23.26b vs Net Y15.22b

Dow Jones
·
Jul 30

Skyworks is Maintained at Underperform by Mizuho

Dow Jones
·
Jul 30

Coupang is Maintained at Neutral by Mizuho

Dow Jones
·
Jul 29

Brown & Brown is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 29

Mizuho Securities Adjusts CMS Energy Price Target to $77 From $78, Maintains Neutral Rating

MT Newswires Live
·
Jul 29

Mizuho Securities Adjusts NXP Semiconductors Price Target to $190 From $200, Maintains Underperform Rating

MT Newswires Live
·
Jul 29

Mizuho Raises Price Target on EyePoint Pharmaceuticals to $39 From $36, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 29

Mizuho Securities Upgrades Lineage to Outperform From Neutral, Raises Price Target to $47 From $40

MT Newswires Live
·
Jul 29

Mizuho Adjusts Price Target on Xylem to $130 From $124, Maintains Neutral Rating

MT Newswires Live
·
Jul 29